Patrick J. Loehrer, MD
Hematology - Oncology
4.8 out of 5 stars
Score is an average rating from all responses on provider-specific questions on our nationally recognized patient experience survey.
Learn About Survey
Learn About Survey
Accepting New Patients
Schedule an Appointment
Already a Patient? Connect on My IU Health
- Biography
- Insurance
- Locations
- Specialties & Details
- Ratings & Reviews
- Clinical Trials
- Related Stories
Biography
Dr. Patrick J. Loehrer specializes in Cancer Treatment for Multi-D Oncology Clinic. Dr. Loehrer earned his medical degree at Rush Presbyterian-St. Lukes Medical Center. He then completed an internship at Rush Presbyterian St Lukes Medical Center a residency at Rush Presbyterian-St. Lukes Medical Center, and a fellowship at Indiana University Medical Center.
Dr. Loehrer currently has a rating of 4.8 stars out of 5 with over 50 ratings. Patients say that he is polite, confident, and impressive.
Dr. Loehrer's primary location is Multi-D Oncology Clinic, 535 Barnhill Dr., Indianapolis, IN 46202.
Insurance
Insurance plans accepted by this provider are below.
- Aetna Medicare Advantage HMO
- Aetna Medicare Advantage POS
- Aetna Medicare Advantage PPO
- Anthem HMO
- Anthem Managed Medicaid Healthy Indiana Plan
- Anthem Managed Medicaid Hoosier Care Connect
- Anthem Managed Medicaid Hoosier Healthwise
- Anthem Medicare Advantage HMO
- Anthem Medicare Advantage PPO
- Anthem PPO
Blue Cross and Blue Shield
- Care Source Healthy Indiana Plan
- Care Source Hoosier Healthwise
- Care Source Marketplace
- Cigna HealthCare HMO
- Cigna HealthCare PPO
- Cofinity (Aetna) PPO
- Cofinity (Aetna) PPOM
Community Health Alliance
Deaconess OneCare
- Encore Combined
- Encore Health Network
First Health Network
- Health Alliance Medicare Advantage
- Humana ChoiceCare
- Humana Medicare Advantage HMO
- Humana Medicare Advantage PFFS
- Humana Medicare Advantage PPO
- IU Health Employee Plan
- IU Health Plans Medicare Advantage HMO
Lutheran Preferred
Majestic Care Management I-SNP
- Managed Health Services Healthy Indiana Plan
- Managed Health Services Hoosier Care Connect
- Managed Health Services Hoosier Healthwise
- Managed Health Services Marketplace
- Managed Health Services Medicare Advantage
- MDWise Excel Healthy Indiana Plan
- MDWise Excel Hoosier Healthwise
Medicaid (Traditional)
Medicare (Traditional)
MultiPlan/PHCS
- Parkview Signature Care EPO
- Parkview Signature Care PPO
Physicians Health Plan of Northern Indiana (PHP)
Sagamore Health Network
SHO Direct
Southern Indiana Health Organization (SIHO) Inspire/PPO
- United HealthCare Managed Medicaid - Hoosier Care Connect
- United HealthCare Medicare Advantage HMO
- United HealthCare Medicare Advantage POS
- United HealthCare Medicare Advantage PPO
VA Community Care Network
- Zing Health CSNP
- Zing Health DSNP
- Zing Health HMO
- Zing Health POS
- Zing Health PPO
Note: Although this listing was accurate at the time of posting, insurances change regularly, and insurance plans listed may not be accepted at all office locations for this provider. Please confirm with your insurance company that this provider is covered by your plan before your appointment.
Locations
Specialties & Details
Specialties:
Hematology - Oncology
Conditions & Treatments:
Gastrointestinal Cancer, Thoracic Cancer, Thymoma Cancer
Education
School of Medicine:
Rush Presbyterian-St. Lukes Medical Center
Internship:
Rush Presbyterian St Lukes Medical Center
Residency:
Rush Presbyterian-St. Lukes Medical Center
Fellowship:
Indiana University Medical Center
Hospitals & Affiliations
Hospital Privileges:
IU Health Methodist/IU Health University, IU Health North
Physician Group:
IU Health Medical Group
Research
Research Publications
* Information provided by PubMed
Related Services
Ratings & Reviews
Clinical Trials
Explore the ongoing clinical trials this provider is involved in and learn about the eligibility requirements for each one. Search the clinical trial directory to find additional clinical trials.
Phase II Randomized Double-Blind Study of mFOLFIRINOX plus Ramucirumab versus mFOLFIRINOX plus placebo in Advanced Pancreatic Cancer Patients HCRN GI14-198
View DetailsMolecular and Pathological Correlates of Treatment Outcome in Patients with Thymoma and Thymic Carcinoma
View DetailsA Phase I/II, Open-Label Study to Investigate the Safety, Clinical Activity, Pharmacokinetics, and Pharmacodynamics of GSK3145095 Administered Alone and in Combination With Anticancer Agents Including Pembrolizumab in Adult Participants With Selected Advanced Solid Tumors
View DetailsRelated Stories
Patient Stories
Read More
Patient is lost for words to describe gratitude - She’s giving back
IU Health Simon Cancer Center — After her own hospitalization, this patient is bri...